Click Here to Register »

2018 Executive Sponsors

Adaptive Biotechnologies
Imaging Endpoints
Mitra Biotech
nanoString Technologies
NeoGenomics

2018 Associate Sponsors

Apogenix
BeiGene
Boston Immunetech
Cancer Genetics
Cytel
Defined health
Exicure
ICON
KIYATEC Inc
Oncorus
PAREXEL
Personalis

2018 Exhibitors

Axio Research
Caprion
Intrinsic Imaging

2018 Supporting Partners

Trout Group

2018 Educational Partners

CIMT
CRI
Patient Empowerment
SITC

2018 Media Partners

BioPharm Insight
BioPharma Dive
CanBiotech
Endpoints News
Pharmalicensing
Pharmaphorum
PharmaVOICE
Technology Networks

Who Should Attend

The program is designed for large pharma, mid-sized biopharma, biotechs and investors seeking to accelerate clinical trials in the emerging immuno oncology space.

Projected Attendee Breakdown

Large Pharma/Biopharma/Biotech responsible for:

  • R&D: Clinical Research/Development, Clinical Operations, Clinical Oncology, Cancer Immunotherapy, Immunology, Translational Research/Development/Medicine, Medical Affairs, R&D Innovation & Strategy, Biomarkers
  • Business Development: Corporate Venture, Licensing, Strategic Partnerships, Negotiations, Early-stage Collaboration, Commercial Innovation, External R&D

Investment Community:

  • Investment Firms
  • Venture Capitals
  • Banks/Financial Institutions
  • Foundation Capital

Academia & Research Organizations focusing on:

  • Immuno-Oncology
  • Immunotherapy
  • Oncology
  • Immunology
  • Immunobiology
  • Cancer Vaccines
  • Clinical Research and Development

Solution Providers:

  • CROs/Clinical Trial Design
  • Diagnostic Testing
  • Molecular Diagnostics
  • Biomarker Software
  • Tumor Biology
  • Assay Development
  • Bi-Specific Antibodies
  • Next Gen Sequencing
  • mRNA / DNA Nucleic Acid Processing
  • RNA Sequencing
  • Cell Analysis/Manufacturing Platforms
  • Monoclonal Antibody (MaB) Engineering
  • Liquid Biopsies
  • Immune Monitoring
  • Cancer Genetics
  • Imaging Services
  • Flow Cytometry
  • Data Analysis/Analytics
  • Laboratory Services
  • Consultants

Our audience is as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change in immuno oncology and support for all those involved in the movement. If you are interested in joining the speaking faculty or audience, please email us at Customer Service.